Literature DB >> 19239137

Beneficial effect of taurine treatment against doxorubicin-induced cardiotoxicity in mice.

Takashi Ito1, Satoko Muraoka, Kyoko Takahashi, Yasushi Fujio, Stephen W Schaffer, Junichi Azuma.   

Abstract

Though the administration of taurine is clinically efficacious against heart failure, the mechanism underlying its cardioprotection remains to be established. To provide information on the mechanism, we examined the effects of taurine on doxorubicin (DOX)-induced cardiotoxicity, with an emphasis on ROS generation and cardiac gene inhibition. Oral administration of taurine (3% w/v in tap water) dramatically reduced the mortality rate in both the acute or sub-acute toxic models of DOX toxicity. It was shown that taurine prevented DOX-induced oxidative stress as determined from cardiac glutathione content. Interestingly, Northern blot analysis revealed that DOX altered cardiac gene expression, including that of alpha-myosin heavy chain, ventricular myosin light chain-2 isoform and brain natriuretic peptide, an effect partially ameliorated by taurine treatment. In conclusion, taurine suppresses ROS generation and regulates gene expression in the DOX treated heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19239137     DOI: 10.1007/978-0-387-75681-3_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

2.  Direct reaction of taurine with malondialdehyde: evidence for taurine as a scavenger of reactive carbonyl species.

Authors:  Guolin Li; Ting Tang; Mijun Peng; Hong He; Dazhong Yin
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

3.  Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction.

Authors:  M Dan McKirnan; Yasuhiro Ichikawa; Zheng Zhang; Alice E Zemljic-Harpf; Sili Fan; Dinesh Kumar Barupal; Hemal H Patel; H Kirk Hammond; David M Roth
Journal:  Life Sci       Date:  2019-02-05       Impact factor: 5.037

4.  Mechanisms and management of doxorubicin cardiotoxicity.

Authors:  Y Shi; M Moon; S Dawood; B McManus; P P Liu
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

Review 5.  Physiological roles of taurine in heart and muscle.

Authors:  Stephen W Schaffer; Chian Ju Jong; K C Ramila; Junichi Azuma
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

6.  Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis.

Authors:  R Jung; M W Wendeler; M Danevad; H Himmelbauer; R Gessner
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

7.  Comparison of the protective actions of N-acetylcysteine, hypotaurine and taurine against acetaminophen-induced hepatotoxicity in the rat.

Authors:  Miteshkumar Acharya; Cesar A Lau-Cam
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

8.  Heat stress in rat adriamycin cardiomyopathy: heat shock protein 25 and Myosin accumulation.

Authors:  Mirian Strauss; Alegna Rada; Félix Tejero; Tomás Hermoso
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

Review 9.  Taurine as a Natural Antioxidant: From Direct Antioxidant Effects to Protective Action in Various Toxicological Models.

Authors:  Peter F Surai; Katie Earle-Payne; Michael T Kidd
Journal:  Antioxidants (Basel)       Date:  2021-11-24

10.  Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis.

Authors:  Brian C Jensen; Traci L Parry; Wei Huang; Ju Youn Beak; Amro Ilaiwy; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Cam Patterson; Gary L Johnson; Monte S Willis
Journal:  Br J Pharmacol       Date:  2017-11-24       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.